Marcin Wozniak will soon join the Beckman Institute for Advanced Science and Technology as its newest Carle Foundation Hospital-Beckman Institute Fellow.
The fellows program, funded by Carle Foundation Hospital, provides a three-year fellowship of interdisciplinary research at the Beckman Institute. This year’s fellowship will focus on heart and vascular research in collaboration with Carle’s Heart and Vascular Institute.
Wozniak earned his Ph.D. from the Department of Medical Laboratory Diagnostics-Biobank in March 2019 at the Medical University of Gdansk, Poland. His work has combined clinical research in cardiovascular science with cutting-edge molecular imaging methods, including Positron Emission Tomography (PET) and X-ray Computed Tomography (CT) imaging with novel and customized molecular probes.
As a visiting scholar, he spent two six-month internships at the Beckman Institute from 2012 to 2014 with Wawrzyniec Dobrucki, an assistant professor of bioengineering and head of the Experimental Molecular Imaging Laboratory (EMIL), where he developed and characterized novel nanoparticle-based probes. His research aims to understand the molecular changes during the evolution of atherosclerosis and to identify the imaging targets for pathologically altered cells in cardiovascular diseases. The principal objective of his studies is the construction of multimodal nanoparticles for theranostic applications including simultaneous drug administration and imaging. One of the imaging targets he is currently investigating is the receptor for advanced glycation end products (RAGE).
Wozniak will be working with Dobrucki and Dr. Issam Moussa, the medical director at Carle’s Heart and Vascular Institute.